PRIMENE 10%
Google image searchProduct monograph
Active ingredients
l-leucine, 1 G/100 ML
l-lysine, 1.1 G/100 ML
l-valine, 760 MG/100 ML
l-isoleucine, 670 MG/100 ML
l-phenylalanine, 420 MG/100 ML
histidine, 380 MG/100 ML
l-threonine, 370 MG/100 ML
l-cysteine, 189 MG/100 ML
methionine, 240 MG/100 ML
tryptophan, 200 MG/100 ML
taurine, 60 MG/100 ML
l-tyrosine, 45 MG/100 ML
glutamic acid, 1 G/100 ML
l-arginine, 840 MG/100 ML
l-alanine, 800 MG/100 ML
l-aspartic acid, 600 MG/100 ML
serine, 400 MG/100 ML
glycine, 400 MG/100 ML
l-proline, 300 MG/100 ML
l-ornithine dihydrochloride, 318 MG/100 ML
DIN: 02236875
Dosage form(s): LIQUID
Route(s) of administration: INTRAVENOUS
Description: AMINO ACID INJECTION
Schedule: Ethical
Company: BAXTER CORPORATION
Date: 19-DEC-2014
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05B — I.V. SOLUTIONS (ATC, ATC/DDD)
- B05BA — Solutions for parenteral nutrition (ATC, ATC/DDD)
- B05BA01 — AMINO ACIDS (ATC/DDD)
Pharmaceutical standard: MFR
External Links for Primene 10%
Search on Google
- Primene 10% side effects
- Primene 10% dosage
- l-leucine side effects
- l-leucine dosage
- l-lysine side effects
- l-lysine dosage
- l-valine side effects
- l-valine dosage
- l-isoleucine side effects
- l-isoleucine dosage
- l-phenylalanine side effects
- l-phenylalanine dosage
- histidine side effects
- histidine dosage
- l-threonine side effects
- l-threonine dosage
- l-cysteine side effects
- l-cysteine dosage
- methionine side effects
- methionine dosage
- tryptophan side effects
- tryptophan dosage
- taurine side effects
- taurine dosage
- l-tyrosine side effects
- l-tyrosine dosage
- glutamic acid side effects
- glutamic acid dosage
- l-arginine side effects
- l-arginine dosage
- l-alanine side effects
- l-alanine dosage
- l-aspartic acid side effects
- l-aspartic acid dosage
- serine side effects
- serine dosage
- glycine side effects
- glycine dosage
- l-proline side effects
- l-proline dosage
- l-ornithine dihydrochloride side effects
- l-ornithine dihydrochloride dosage
